Skip to content

Acceptance & Commitment Therapy for Psychotic Inpatients

Acceptance & Commitment Therapy for Psychotic Inpatients

Status
Withdrawn
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02458105
Enrollment
0
Registered
2015-05-29
Start date
2015-04-30
Completion date
2017-12-31
Last updated
2018-05-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Psychosis

Keywords

Acceptance and commitment therapy, Cognitive behavior therapy

Brief summary

The overarching aim of the research project is to investigate whether Acceptance & Commitment Therapy (ACT) is an efficacious psychotherapeutic method of treatment for inpatients suffering from acute psychosis. The method will be applied in two ways. Firstly, as an individual treatment for patients. Secondly, as an integrated part of the daily work on an inpatient ward, administered by nurses and assistant nurses trained in the method.

Interventions

A variant of cognitive behavior therapy focused on acceptance and valued living in the presence of distressing symptoms.

BEHAVIORALAttention

Supportive conversation at a frequency and length corresponding to the experimental condition.

Sponsors

Stockholm University
CollaboratorOTHER
Uppsala University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Admitted to a specified psychiatric inpatient ward during the time-period of the study; psychotic spectrum diagnosis as specified in patient charts; assessed by contact person on the ward as having delusions or hallucinations.

Exclusion criteria

* Cognitive difficulties to an extent where informed consent cannot be given.

Design outcomes

Primary

MeasureTime frameDescription
Rehospitalization12 monthsWhether or not, and if so for how many days, a patient has ben readmitted to inpatient care during the follow-up period.

Secondary

MeasureTime frameDescription
EQ-5D12 monthsHealth related quality of life instrument to be administered before treatment, after treatment, and at 3, 6 and 12 month follow-up.
Clinical Global Impression Scale12 monthsSymptom severity instrument to be administered before treatment, after treatment, and at 3, 6 and 12 month follow-up.
Bull's Eye Values Inventory12 monthsQuality of life instrument to be administered before treatment, after treatment, and at 3, 6 and 12 month follow-up.
Psychotic Symptom Rating Scales12 monthsSymptom severity instrument to be administered before treatment, after treatment, and at 3, 6 and 12 month follow-up.
Checklist of Unit BehaviorsDuring inpatient care.Measure for degree of activity on the ward.
Acceptance & Action Questionnaire12 monthsPsychological flexibility instrument to be administered before treatment, after treatment, and at 3, 6 and 12 month follow-up.

Countries

Sweden

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026